- Home
- KRC vs SHC Comparison
KRC vs SHC Comparison
Compare KRC & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRC | SHC |
|---|---|---|
| Founded | 1947 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.0B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KRC | SHC |
|---|---|---|
| Price | $34.86 | $18.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $37.36 | $20.33 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.57% | N/A |
| EPS Growth | 31.07 | ★ 68.75 |
| EPS | N/A | ★ 0.28 |
| Revenue | $1,112,667,000.00 | ★ $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | $2.13 | $6.00 |
| P/E Ratio | ★ N/A | $65.61 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $27.36 | $13.09 |
| 52 Week High | $45.03 | $19.85 |
Technical Indicators
Market Signals| Indicator | KRC | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.24 | 47.56 |
| Support Level | $33.29 | $18.39 |
| Resistance Level | $35.69 | $18.55 |
| Average True Range (ATR) | 0.78 | 0.38 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 14.66 | 29.65 |
Price Performance
Historical ComparisonAbout KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 16.3 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.
About SHC Sotera Health Company
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.